PD-1 (Programmed Cell Death Protein 1) is a checkpoint protein on T-cells. In lung cancer, tumor cells express PD-L1, which binds to PD-1, inhibiting T-cell activity and causing 'exhaustion'.

Yes. Recent evidence suggests that **terminally exhausted** T-cells may be epigenetically scarred and fail to recover function even after PD-1 blockade.